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Background: Joint surface injury, a known risk factor for osteoarthritis, triggers synovial hyperplasia, which involves
proliferation of mesenchymal stromal/stem cells (MSCs). Whether these proliferative MSCs are resident synovial cells
or move into the tissue from elsewhere is not known. The aim of this study was to determine the contribution of
bone marrow-derived cells to synovial hyperplasia following joint surface injury.
Methods: Lethally irradiated mice were transplanted with green fluorescent protein (GFP)-labelled bone marrow,
and MSC chimerism was determined by the colony-forming unit fibroblast (CFU-F) assay and phenotypic analysis.
To label host slow-cycling cells prior to bone marrow transplant, mice received iododeoxyuridine for 3 weeks. Mice
then were subjected to GFP+ bone marrow transplant, underwent joint surface injury and received chlorodeoxyuridine
(CldU) for 7 days to label cells proliferating after injury. GFP- and nucleoside-labelled cells in normal and injured knee
joint synovium were quantified in situ by immunofluorescence staining of paraffin-embedded tissue sections. The
phenotype of GFP-labelled cells was determined by co-staining for the haematopoietic marker CD16/CD32 and the
MSC/fibroblast marker platelet-derived growth factor receptor α (Pdgfrα).
Results: CFU-F assay and phenotypic analysis demonstrated successful bone marrow mesenchymal lineage chimerism
in mice that underwent transplants. Bone marrow reconstitution preceded the detection of GFP-labelled cells
in synovium. The percentage of GFP+ cells in synovium increased significantly in response to injury, while the
proportion of GFP+ cells that were labelled with the proliferation marker CldU did not increase, suggesting that the
expansion of the GFP+ cell population in synovium was due mainly to bone marrow cell infiltration. In contrast,
proliferation of host slow-cycling cells was significantly increased in the hyperplastic synovium. In both control and
injured knee joints, the majority of marrow-derived GFP+ cells in the synovium were haematopoietic (CD16/32+), while
a minority of cells expressed the pan-fibroblast/MSC marker Pdgfrα.
Conclusions: Our findings indicate that synovial hyperplasia following joint surface injury involves proliferation of
resident slow-cycling cells, with a contribution from infiltrating bone marrow-derived cells. Understanding the process
of synovial hyperplasia may reveal ways to restore homeostasis in injured joints and prevent secondary osteoarthritis.
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Synovium is a membrane that lines the cavity of synovial
joints and consists of a lining layer of macrophage-like
synoviocytes and fibroblast-like synoviocytes (FLS), as
well as a sublining of connective tissue [1]. Synovial cells
are thought to contribute to joint homeostasis by secreting
various factors such as hyaluronic acid and lubricin
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factors such as trauma and inflammation (arthritis), with
aberrant proliferation of stromal cells resulting in synovial
hyperplasia, which can become clinically prominent by
causing pain and swelling.
Joint injury is a known risk factor for secondary osteo-
arthritis [2] and triggers an accompanying synovial
hyperplasia whose biological events remain poorly
understood. An understanding of the events occurring
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ventions for osteoarthritis [3].
We recently provided evidence that mesenchymal
stromal/stem cells (MSCs) are key players in synovial
hyperplasia secondary to joint surface injury [4]. First
isolated from bone marrow [5, 6], MSCs were later
established in vitro from several connective tissues as
fibroblast-like cells with abilities to form colonies de-
rived from single cells (colony-forming unit fibroblasts
[CFU-F]) and to give rise to mature cells of mesenchy-
mal lineages such as osteoblasts and chondrocytes [7].
We previously reported the isolation and characterisa-
tion of multipotent MSCs from the adult human
synovium [8–11]. More recently, we employed a double-
nucleoside analogue labelling method to demonstrate
the in vivo identification and location of MSCs in the
mouse synovium, and showed that following joint
surface injury these cells proliferated to sustain synovial
hyperplasia [4]. Whether these proliferative MSCs in
hyperplastic synovium are resident synovial cells or
move into the tissue from elsewhere is not known.
There is evidence that bone marrow cells can migrate
into synovium, raising the possibility that an influx of
bone marrow-derived cells may contribute to the pool of
proliferating MSCs during injury-induced synovial
hyperplasia [12–14]. In an early study by Edwards et al.
[12], wild-type mice subjected to beige mouse-derived
bone marrow transplants showed the emergence in their
synovium of donor-derived cells, which appeared to be
macrophage-like synoviocytes on the basis of their
morphology as analysed by electron microscopy. How-
ever, the detection rate of the characteristic large gran-
ules in synovium of beige donor mice themselves was
less than one in ten cells, and it was not clear whether
the large granules were more prevalent or readily detect-
able in cells of the monocyte lineage [12]. In more
recent studies, researchers have investigated the influx
of bone marrow cells into synovium under inflammatory
conditions using murine models of rheumatoid-like
inflammatory arthritis. Marinova-Mutafchieva et al. [13]
identified a population of mesenchymal progenitor cells
on the basis of expression of bone morphogenetic
protein receptor types 1A and 2 (BMPR1A and BMPR2,
respectively), which were not found in normal synovium
but accumulated in synovium in the collagen-induced
arthritis (CIA) model. BMPR-expressing cells were
present in epiphyseal bone marrow of control mice and
were suggested to infiltrate the synovium of CIA mice
through enlarged bone canals connecting the two tissues
[13]. Li and Makarov [14] transplanted green fluorescent
protein (GFP)-labelled bone marrow cells into wild-type
mice and then induced antigen-induced arthritis.
Primary FLS cultures established from arthritic joints
and expanded to passage 3 contained over 30 % of GFP+(bone marrow-derived) cells, significantly higher than
the approximately 1 % observed in cultures obtained
from healthy joints. On the basis of their plastic
adherence, the donor-derived cells in the FLS cultures
were suggested to be mesenchymal cells, though no
phenotypic characterisation was presented [14].
Altogether, these studies suggest that under normal
conditions there is minimal, if any, migration of mesen-
chymal cells from bone marrow to synovium, and that
in rheumatoid-like inflammatory arthritis an influx of
bone marrow-derived mesenchymal cells may contribute
to synovial pannus formation. Whether such an influx of
bone marrow cells contributes to the synovial hyperpla-
sia accompanying non-inflammatory joint disorders such
as trauma is not known.
In this study, we set out to investigate the contribution
of bone marrow MSCs to synovial hyperplasia following
joint surface injury. To this end, we established a mouse
MSC chimeric model via transplant of genetically
labelled bone marrow into lethally irradiated mice and
characterised bone marrow-derived cells in the synovium
of normal knee joints and after joint surface injury [15].
Our study provides evidence that the majority of the
MSCs that proliferate after injury are resident synovial
cells, with a contribution to the synovial hyperplasia from
increased infiltration of predominantly haematopoietic
bone marrow-derived cells.Methods
Animals
The animal experiments were approved by the U.K. Home
Office and conducted in accordance with the U.K.’s Ani-
mals (Scientific Procedures) Act 1986 and the U.K. Home
Office Code of Practice. Wild-type C57BL/6 mice were
purchased from Charles River Laboratories (Edinburgh,
UK). C57BL/6-Tg14(act-EGFP)OsbY01 mice (referred to
hereafter as Act-eGFP), which express enhanced GFP
ubiquitously [16], were bred in our animal facility (origin-
ally obtained from Prof. Okabe, Genome Information
Research Centre, Osaka University, Osaka, Japan).Bone marrow transplant
Bone marrow transplants were performed as previously
described [17]. Mice (7- to 9-week-old females) received
full-body irradiation in two doses of 5 Gy given 3 h
apart. The donor cells were isolated by flushing bone
marrow cells from the femur, tibia, and pelvis with PBS
supplemented with 2 % foetal calf serum (FCS). A total
of 5 × 106 donor cells per mouse were delivered 24 h
after irradiation via tail vein injection. Chimerism was
determined in a peripheral blood sample obtained from
the tail vein at 3 weeks post-transplant using flow
cytometry.
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The joint surface injury procedure was performed as
previously described [15]. Briefly, 3 to 4 weeks after bone
marrow transplant, mice were anaesthetised and
subjected to surgery under a dissection microscope. An
incision was made to open the skin over the knee joint
area, followed by an incision along the medial side of the
patellar ligament and through the quadriceps muscle to
aid patellar dislocation. The patellar groove was exposed
and a full-cartilage-thickness scratch along the length of
the groove was made using a 25-gauge needle. The
patella was then relocated, and the joint capsule and the
skin were sutured. The contralateral knee served as an
uninjured internal control. Sham-operated knee joints
were subjected to arthrotomy, but no cartilage injury
was made.
Nucleoside analogue administration
Nucleoside analogue administration was performed as
previously described [4]. Briefly, 4-week-old mice re-
ceived iododeoxyuridine (IdU; Sigma-Aldrich, Dorset,
UK) in drinking water (1 mg/ml) for 3 weeks, followed
by a 5-week wash-out period. Immediately after joint
surface injury, mice received an injection of chlorodeox-
yuridine (CldU; Sigma-Aldrich) subcutaneously (10 mg/
ml) and then received CldU in their drinking water
(1 mg/ml) for 7 days.
Bone marrow cell isolation
Bone marrow cells were isolated as previously described
[18]. Briefly, mouse limbs were dissected and muscles
were removed using a scalpel. Bones were then cut into
small fragments using scissors, washed three times with
HBSS+ buffer (Hank’s balanced salt solution [HBSS]
supplemented with 2 % FCS, 10 mM HEPES, and 1 %
penicillin [10,000 U/ml]/streptomycin [10 mg/ml]) and
incubated in pre-warmed DMEM supplemented with
0.2 % collagenase type I (Sigma-Aldrich), 10 mM HEPES
and 1 % penicillin (10,000 U/ml)/streptomycin (10 mg/ml)
for 1 h in a water bath shaken at 140 rpm. Samples were
vortexed every 10 minutes to assist cell dissociation. After
collagenase incubation, the supernatant was collected
through a 70-μm filter, and bones were further crushed in
a mortar with pestle with approximately 50 taps. The
crushed bone fragments were washed with HBSS+ buffer
several times until clear, and all collected cells were pel-
leted. After red blood cells were lysed using BD Pharm
Lyse buffer (BD Biosciences, Oxford UK), cells were
washed and viable cells were counted using trypan blue
exclusion.
CFU-F assay
Bone marrow cells were seeded at 2.5 × 104 cells/cm2
and maintained in MesenCult MSC Basal Mediumsupplemented with MesenCult Stimulatory Supplements
(STEMCELL Technologies, Vancouver, BC, Canada) in
accordance with the manufacturer’s instructions for
2 weeks, after which the number of CFU-F was scored.
Clusters of ≥32 cells were considered colonies.
Thirty-two cells were chosen because this represents
a population of cells derived from at least five population
doublings of a single cell, thereby discounting transit-
amplifying cells [19]. GFP fluorescence was detected using
an EVOS FL microscope (Life Technologies, Carlsbad,
CA, USA).
Flow cytometry
Mononuclear cells from peripheral blood were stained
with CD45-peridinin chlorophyll protein complex
(PerCP)-cyanine 5.5 (Cy5.5) antibody (clone 30-F11;
eBioscience, San Diego, CA, USA). Freshly isolated bone
marrow cells were co-stained with CD45-phycoerythrin
(clone 30-F11; BD Biosciences), CD140a-allophycocyanin
(clone APA5; BD Biosciences) and stem cell antigen 1
(Sca-1)-PerCP-Cy5.5 (clone D7; eBioscience) antibodies
for 30 minutes at 4 °C. Cells were analysed using a BD
LSR II flow cytometer (BD Biosciences). Dead cells were
excluded from the analysis based on staining with eFluor
780 viability dye (65-0865; eBioscience).
Histology
Knee joints were fixed in 4 % methanol-free paraformal-
dehyde (TAAB Laboratories Equipment, Aldermaston,
UK) for 24 h at 4 °C and then decalcified in 10 % ethyl-
enediaminetetraacetic acid (EDTA) (VWR International,
Lutterworth, UK) in PBS for 2 weeks. The samples were
then either embedded in paraffin and cut into 5-μm
sections using a standard microtome (Leica RM2125 RT;
Leica Biosystems, Milton Keynes, UK) or, to directly
visualise GFP under a fluorescence microscope incubated
sequentially in 15 % and 30 % sucrose in PBS, embedded
in O.C.T. compound (VWR International) over liquid
nitrogen and cut into 8-μm sections using a cryostat
(Leica CM1850 UV; Leica Biosystems). Haematoxylin and
eosin (H&E) staining was performed according to standard
protocols.
Immunofluorescence staining
Immunofluorescence staining of paraffin sections was per-
formed as previously described [4], with some modifica-
tions. Antigen retrieval was either (1) enzyme-based by
incubation with 1 mg/ml to 3 mg/ml porcine pepsin
(Sigma-Aldrich) for 45 minutes at 37 °C or (2) heat-
mediated in an EDTA-based solution (pH 9; Vector La-
boratories, Burlingame, CA, USA) or citrate buffer solution
(pH 6; Vector Laboratories) for 30 minutes in a steamer.
Autofluorescence was quenched by incubation in 1 %
Sudan Black B (Sigma-Aldrich) solution (in 70 % ethanol)
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ing was blocked with 1 % bovine serum albumin (Sigma-
Aldrich) for 1 h. Sections were then incubated with primary
antibodies (listed in the subsection immediately below)
overnight at 4 °C in a humidified chamber, followed by in-
cubation with Alexa Fluor 488- or Alexa Fluor 594-
conjugated secondary antibodies (Life Technologies) for
1 h at room temperature in the dark. The nuclei were
counterstained with 4′,6-diamidino-2-phenylindole (DAPI,
Life Technologies).
Antibodies
The following primary antibodies were used: anti-GFP
(chicken polyclonal antibody; Abcam, Cambridge, UK),
anti-GFP (rabbit monoclonal antibody; Abcam), anti-
bromodeoxyuridine (rat monoclonal antibody, clone
ICR1, cross-reacts with CldU but not with IdU; Abcam),
anti-IdU (mouse monoclonal antibody, clone 32D8.D9;
Abcam), anti-von Willebrand factor (anti-vWF) (rabbit
polyclonal antibody; Dako, Ely, UK), anti-platelet-derived
growth factor receptor α (anti-Pdgfrα) (rabbit polyclonalFig. 1 Synovial hyperplasia following joint surface injury. a Haematoxylin an
knee joint. Boxed area indicates the area of synovium analysed in b and c. Arro
b H&E-stained histological sections of uninjured (control), sham-operated and i
injury. L lining, SL sublining, C capsule, P patella, F femur. Scale bars = 100 μm. c
from images as in b, showing a significant increase in cellularity in both the to
knees, as compared with uninjured controls. Data are expressed as the average
data points from four (uninjured and sham controls) or eight (injured) mice, witantibody; Abcam) and anti-CD16/CD32 (goat monoclo-
nal antibody; R&D Systems, Minneapolis, MN, USA).Imaging and cell counting
Images of both cryosections and paraffin-embedded
sections were acquired using a Zeiss LSM 710 confocal
microscope (Carl Zeiss Microscopy, Jena, Germany) for
fluorescence analysis or a Zeiss Imager Axioskop 40
microscope (Carl Zeiss Microscopy) equipped with a
ProgRes C14 camera (Jenoptik, Jena, Germany) for
H&E-stained sections. Image processing and manual cell
counting were performed using ZEN 2010 (Carl Zeiss
Microscopy) or ImageJ (National Institutes of Health,
Bethesda, MD, USA) software. For each condition, three
sections per knee joint from at least three mice were
analysed. A minimum of 200 total cells from each mouse
knee joint were counted. To avoid the confounding in-
fluence of the medial parapatellar arthrotomy in injured
knee joints, quantification was carried out in the lateral
compartment of the knee.d eosin (H&E)-stained histological section of an injured 14-week-old mouse
w indicates joint surface injury. P patella, F femur. Scale bar = 800 μm.
njured knee joint synovium showing hyperplasia 6 days after joint surface
Number of cells in the total, lining and sublining of synovium, quantified
tal synovium and the synovial lining of injured but not sham-operated
number of cells per quantified histological section and shown as individual
h horizontal lines indicating mean values. **p< 0.01; ***p< 0.001
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Data were analysed using IBM SPSS (IBM, Armonk, NY,
USA) and Prism (GraphPad Software, La Jolla, CA, USA)
software. Statistical significance was determined using
either t tests for two-group comparisons, or two-way ana-
lysis-of-variance and the Bonferroni post-hoc test for multi-
group comparisons, with p < 0.05 considered significant.
Results
Synovial hyperplasia following joint surface injury
We previously showed extensive proliferation of label-
retaining cells with an MSC phenotype in the synovium
of knee joints challenged with an injury to the articular
surface of the femoral groove, while little proliferation
was observed in the synovium of sham-operated knees
[4]. To confirm that the synovial hyperplasia in this
model is specific to the joint surface injury, the syno-
vium near the patellofemoral junction of uninjured,
sham and injured knee joints was evaluated by H&EFig. 2 Assessment of bone marrow stromal cell chimerism. C57BL/6 mice r
GFP-labelled bone marrow from C57BL/6-Tg14(act-EGFP)OsbY01 donor mic
CFU-F assay, phenotypic analysis of bone marrow cells and histology after
were GFP+ (donor-derived). Data are shown as individual data points from
group. b GFP positivity in the CD45−/dimPdgfrα+Sca-1+ bone marrow MSC
gating strategy. Gating for GFP was based on a WT mouse sample. The perce
shown as mean ± SD (n = 7). c Confocal microscopic images showing a GFP+
cells (arrows) in bone (B) (ii) and bone marrow (iii), GFP+ bone lining cells (arro
in bone matrix (v). Scale bars = 25 μm. CFU-F colony-forming unit fibroblasts, F
Sca-1 stem cell antigen 1, SSC side scatter, WT wild-type, GFP green fluorescenstaining (Fig. 1a and b). Of note, the surgical incision to
access the joint was made on the medial side of the
knee, while the lateral side was analysed to assess the
synovial response to injury. Cellularity in injured knee
joint synovium increased 2.5-fold compared with unin-
jured controls (p < 0.001) and 2.8-fold compared with
sham-operated controls (p < 0.001). The increase in
cellularity was observed predominantly in the lining
(p < 0.01). Importantly, the cellularity of synovium from
sham-operated knees did not significantly change com-
pared with uninjured control knees (Fig. 1c). Taken
together, these data show that synovial hyperplasia in the
lateral compartment of the knee occurs in response to the
injury of the joint surface and not the arthrotomy.
Mesenchymal lineage chimerism after bone marrow
transplant
To investigate the contribution of bone marrow-derived
cells to synovial hyperplasia following joint surfaceeceived total body irradiation and were subjected to transplant with
e. Mesenchymal stromal cell lineage chimerism was determined by
8 weeks. a CFU-F assay results showing that the vast majority of CFU-F
six mice for the transplanted group and three mice for the WT control
population. Shown are representative flow cytometry plots indicating
ntage of CD45−/dimPdgfrα+Sca-1+ cells positive for GFP (donor-derived) is
osteoclast (arrow) in the growth plate (GP) region (i), GFP+ perivascular
ws) at the endosteal surface (iv) and a GFP+ osteocyte (arrow) embedded
SC forward scatter, Pdgfrα platelet-derived growth factor receptor α,
t protein, GP growth plate, B bone, MSC mesenchymal stromal/stem cell
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to label bone marrow-derived cells [17]. Wild-type
C57BL/6 mice were lethally irradiated and subjected to
transplant of GFP-labelled bone marrow cells derived
from transgenic Act-eGFP mice. At 3 weeks after trans-
plant, more than 90 % of CD45+ cells in peripheral
blood were GFP-labelled (data not shown), thereby con-
firming successful haematopoietic lineage chimerism.
To determine the degree of MSC chimerism in the
bone marrow stromal compartment, we employed a
standard CFU-F assay using freshly isolated bone mar-
row cells (Fig. 2a). The numbers of CFU-F ranged from
3 to 31 per 106 bone marrow cells (average 16 CFU-F/
106 cells, n = 6). When analysed for GFP expression,
approximately 90 % of the colonies were GFP+. Bone
marrow derived from control mice that did not undergo
transplants contained 39 ± 11 CFU-F per 106 cells (n = 3)
(Fig. 2a).
To further determine whether MSCs in bone marrow
were successfully labelled, freshly isolated (uncultured)
MSCs were identified on the basis of their CD45−/dimPdg-
frα+Sca-1+ phenotype, as previously reported [18]. The
percentage of GFP+ cells within the Pdgfrα+Sca-1+ MSC
fraction, which constituted 0.14 ± 0.07 % of isolated
CD45−/dim cells, was 71.3 ± 11.2 % (n = 7) (Fig. 2b).
Bone marrow chimerism was confirmed by histological
analysis, which showed the presence of GFP-labelled cells
not only within the haematopoietic compartment (includ-
ing large, multinucleated osteoclasts; Fig. 2c-i) but also in
the bone marrow stroma, including perivascular cells
(Fig. 2c-ii, iii), bone lining cells covering the endosteal sur-
faces (Fig. 2c-iv) and osteocytes embedded within the
bone matrix (Fig. 2c-v). Taken together, the CFU-F and
phenotypic studies of freshly isolated bone marrow cells
and the histological analyses of cryosections demonstrated
efficient mesenchymal lineage chimerism in the bone mar-
row of transplanted mice.Fig. 3 Detection of green fluorescent protein-positive (GFP+) cells in
the synovium of bone marrow chimeric mice. a Representative confocal
microscopic images of knee joint cryosections showing GFP+ (green)
cells in the bone marrow (BM) and synovium (S) with 4′,6-diamidino-2-
phenylindole (DAPI) (blue) counterstaining at multiple time points
following bone marrow transplant as indicated. Scale bars = 50 μm.
b Quantification of donor-derived GFP+ cells in bone marrow and
synovium as percentages of total nucleated cells at the indicated time
points post-transplant. Data are shown as individual data points from
three mice. Horizontal lines indicate mean values. p< 0.0001 by two-way
analysis of variance of bone marrow versus synoviumBone marrow-derived cells in the synovium of mice that
received transplants
We next monitored over time the numbers of donor-
derived GFP+ cells in bone marrow and synovium. GFP+
cells were detected in the bone marrow as early as 3 h
post-transplant and increased to 76.8 ± 2.5 % of cells at
7 days (Fig. 3), showing the rapid homing to and recon-
stitution of the bone marrow by systemically injected
donor cells, as expected. In contrast, GFP+ cells were
not detected in the synovium at the early 3- and 24-h
time points. They were first detected in small numbers
at 7 days (4.7 ± 1.8 % of total cells) and increased to
28.3 ± 4.4 % of total cells at 8 weeks (Fig. 3). These data
suggest a gradual, continuous migration of bone
marrow-derived cells into the synovium, which occurs
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marrow.
Contribution of bone marrow-derived cells to synovial
hyperplasia following joint surface injury
To assess the contribution of bone marrow-derived cells
to synovial hyperplasia after joint trauma, chimeric mice
carrying GFP-labelled bone marrow were challenged
with joint surface injury. Double-nucleoside labelling [4]
was used to identify host-derived MSCs by giving miceFig. 4 Detection of GFP+ cells in synovium of bone marrow chimeric mice fo
design for the data shown in this figure and Fig. 5. b Representative images o
marker CldU (red) in control and injured knee joint synovium. Nuclei are coun
bars = 25 μm. The insets show magnified views of the areas within dotted rect
Quantification of GFP and CldU single- and double-positive cell populations in
with horizontal lines indicating mean values. **p < 0.01; ***p < 0.001. Act-eGFP
fluorescent protein, IdU iododeoxyuridinethe nucleoside analogue IdU for 3 weeks prior to bone
marrow transplant. Immediately after injury, mice
received a second nucleoside analogue, CldU, for 7 days
to label proliferating cells until tissues were collected for
analysis (Fig. 4a). Immunofluorescent staining of
paraffin-embedded knee joint sections was used to
detect labelled cells.
We initially focussed on the GFP-labelled, bone
marrow-derived donor cells (Fig. 4b). Quantitative ana-
lysis revealed a significant increase in the percentage ofllowing joint surface injury. a Schematic diagram showing experimental
f immunofluorescent staining for GFP (green) and the proliferation
terstained with 4′,6-diamidino-2-phenylindole (DAPI; blue). Scale
angles. BM bone marrow, S synovium, C capsule, P patella, F femur. c–e
the synovium. Data are shown as individual data points from three mice,
C57BL/6-Tg14(act-EGFP)OsbY01 mice, CldU chlorodeoxyuridine, GFP green
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contralateral control knee joint synovium (12.5 ± 3.6 %,
n = 3; p < 0.01) (Fig. 4c), demonstrating an expansion of
the bone marrow-derived cell population in synovium
after injury. However, the percentage of GFP+ cells that
were positive for the proliferation marker CldU did not
change significantly following injury (Fig. 4d), suggesting
that the increase in GFP+ cells in synovium was due
mainly to increased infiltration of donor-derived cells
rather than a proliferative response to the injury. In
contrast, the percentage of GFP− cells that were CldU+
significantly increased (p < 0.001) (Fig. 4e).
To ascertain that the cells in synovium that proliferated
after injury were host-derived, label-retaining cells, we
performed double-immunofluorescence staining for IdU
and CldU (Fig. 5a). Quantitative analysis showed that the
percentage of total IdU+ cells increased significantly from
11.8 ± 4.0 % in the synovium of uninjured control joints to
25.8 ± 3.5 % in injured joints (p < 0.01, n = 3) (Fig. 5b).
Moreover, the percentage of proliferative CldU+ cellsFig. 5 Proliferation of host slow-cycling cells in synovium following joint
surface injury. The schematic diagram of the experimental design is
shown in Fig. 4a. a Representative images of immunofluorescent
staining for iododeoxyuridine (IdU, green) and chlorodeoxyuridine
(CldU, red) in control and injured knee joint synovium. Nuclei are
counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue). Scale
bars = 25 μm. The insets show magnified views of the areas within
dotted rectangles. S synovium, C capsule, P patella, F femur. b, c
Quantification of nucleoside analogue-labelled cells in the synovium.
Data are shown as individual data points from three mice, with
horizontal lines indicating mean values. *p < 0.05; **p < 0.01within the IdU+ population strongly increased (p < 0.05,
n = 3) (Fig. 5c). This confirmed that the label-retaining
cells from the host retained their ability to proliferate
and were major contributors to the synovial hyperplasia
in the bone marrow transplant model.
Phenotypic characterisation of bone marrow-derived cells
in the synovium
We investigated the phenotype of bone marrow-derived
GFP+ cells in the synovium by immunofluorescence
staining for GFP in conjunction with cell lineage
markers (Fig. 6a). The majority of GFP+ cells in the
control synovium of uninjured joints expressed the
haematopoietic marker CD16/CD32, known to be
expressed by macrophages in the synovial lining [20],
while a very small number of GFP+ cells were positive
for the pan-fibroblast/MSC marker Pdgfrα [18, 21]
(Fig. 6b). After injury, the majority of GFP+ cells in syno-
vium remained positive for CD16/CD32, with a minor
contribution from Pdgfrα+ MSCs/fibroblasts, both at
7 days post-injury (7dpi), when synovial hyperplasia was
florid, and at 4 weeks post-injury (4wpi), when hyperpla-
sia had decreased (Fig. 6b). Conversely, a substantial
proportion of the CD16/32+ haematopoietic cells in
synovium were donor-derived in both control and in-
jured knee joints, while the proportion of GFP-labelled
cells within the Pdgfrα+ MSC/fibroblast population was
low and remained low after injury, both at 7dpi and
4wpi (Fig. 6c). No co-localisation of GFP and the endo-
thelial cell marker vWF was detected in synovium (data
not shown). Taken together, these findings indicate that
the GFP+ bone marrow-derived cells in the synovium
are mostly of haematopoietic lineage.
Discussion
Synovial hyperplasia is a frequent clinical finding in patients
with joint disorders. Its pathogenesis is likely to be distinct,
depending on the underlying clinical condition. While it is
driven in large part, if not entirely, by inflammation/auto-
immunity in rheumatoid arthritis, its pathogenesis in pa-
tients with joint trauma or osteoarthritis is not so well
defined [22]. We recently identified the MSC as a key cell
player in synovial hyperplasia secondary to joint surface
injury in mice by demonstrating that label-retaining cells
with an MSC-like phenotype undergo a burst of pro-
liferation, which results in an expansion of the MSC
pool associated with a thickening of the synovium [4].
Human synovium is also known to contain MSCs [8–11],
raising the possibility that a similar cell population may
underpin the synovial hyperplasia in patients after joint
trauma. However, bone marrow is also well known to
harbour MSCs [7] and is connected to the synovium and
joint space via bone canals. It is therefore conceivable
that an influx of cells from bone marrow into synovium
Fig. 6 Phenotypic characterization of GFP+ cells in synovium. a Paraffin-embedded sections from control and injured knee joints at 7 days post-injury
(7dpi) and 4 weeks post-injury (4wpi) were subjected to immunofluorescence staining for GFP (green) in conjunction with CD16/CD32 (red) or Pdgfrα
(red) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue). Scale bars = 25 μm. The insets show magnified views of the areas within
dotted boxes. S synovium, C capsule, P patella, F femur. b, c GFP+CD16/CD32+ cells and GFP+Pdgfrα+ cells in the synovium shown as percentages of
(b) the total GFP+ cell population and (c) the total marker-positive cell population. Data are shown as individual data points from three mice, with
horizontal lines indicating mean values. GFP green fluorescent protein, Pdgfrα platelet-derived growth factor receptor α
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plasia, as suggested by previous studies in rodent
models of inflammatory arthritis [13, 14].
In the present study, we show that hyperplasia of the
synovium in the lateral compartment of the knee joint
following surgically induced injury that involved medialarthrotomy to access the joint specifically occurred in
response to the joint surface damage, as no hyperplasia
was observed in the lateral synovium of sham-operated
knee joints. The increased cellularity of the synovium
after joint surface injury was most notable in the syn-
ovial lining.
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populations to synovial hyperplasia secondary to joint sur-
face injury, we carried out transplant of genetically la-
belled bone marrow into lethally irradiated wild-type
mice. Following the bone marrow transplant protocol out-
lined by Koide et al. [17] and Morikawa et al. [18], we
achieved comparable bone marrow stromal cell compart-
ment reconstitution with genetically labelled donor cells
as assessed by CFU-F assay, analysis of the CD45
−Pdgfrα+Sca-1+ MSC population and histological cell
assessment. The CFU-F assay indicated around 90 % effi-
ciency of stromal cell chimerism in bone marrow, while
the flow cytometry analysis of the CD45−Pdgfrα+Sca-1+
MSC population revealed approximately 70 % of the con-
tribution to be from the donor. This difference could be
due to different sensitivities of the assays used to detect
MSCs or to host cells losing their proliferative capacity
in vitro as a consequence of the total body irradiation
prior to bone marrow transplant [18]. The latter, however,
did not appear to be true for the stromal cells in syno-
vium, which displayed a high degree of proliferation after
injury similar to what we reported previously in non-
irradiated mice [4]. The efficiency of the stromal cell re-
constitution following bone marrow transplant was fur-
ther corroborated by the detection of donor-derived cells
along the mesenchymal lineage, including bone lining cells
and osteocytes, and cells in a perivascular location, a
known niche for MSCs in bone marrow [23–25].
Trafficking of bone marrow-derived MSCs into organs
and tissues has been reported to occur in intestine and
muscle [26], and also in skin [27]. Studies of the contri-
bution of bone marrow-derived MSCs to synovium are
limited, and mostly in the context of inflammatory/auto-
immune arthritis. Marinova-Mutafchieva et al. [13] re-
ported accumulation in the synovium of rheumatoid-like
CIA mice of BMPR-expressing mesenchymal progenitor
cells, not detected in normal synovium, an accumulation
that was thought to occur through infiltration from bone
marrow via enlarged bone canals. Likewise, Li and
Makarov [14] reported an increase in bone marrow-
derived MSC contribution to the synovium during
antigen-induced inflammatory arthritis using a GFP-
labelled bone marrow transplant model in wild-type
mice. We employed a similar chimeric model to focus
our analysis on the synovial hyperplasia secondary to
joint surface injury, and to this end we elected to use a
clinically relevant knee joint trauma model that is not
driven by overt inflammatory or autoimmune events
[15]. Our findings showing an influx of bone marrow-
derived cells into a trauma-induced hyperplastic syno-
vium are novel in the context of joint trauma and, due
to different aetiopathogenesis, cannot be compared with
those obtained using inflammatory/autoimmune models
of synovial hyperplasia (synovitis).The increase in bone marrow-derived cells in syno-
vium following joint surface injury was likely due to
enhanced infiltration of cells from the bone marrow
and/or circulation rather than increased proliferation
in situ, since the proportion of donor-derived cells in
synovium that proliferated did not increase after in-
jury. We monitored the transplanted cells over time
to ascertain that the systemically injected donor cells
did not immediately home to the synovium, but
rather gradually infiltrated the synovial tissue over the
course of several weeks.
Most of the GFP+ cells in synovium were of haemato-
poietic lineage (CD16/32+), while few expressed the pan-
fibroblast/MSC marker Pdgfrα [18, 21]. Interestingly,
while there was an overall increase in bone marrow-
derived GFP+ cells in synovium following injury, the
proportions of haematopoietic and stromal cells
remained similar, indicating there was no clear preferen-
tial or selective expansion of one cell population over
other cell populations. This would support homing as a
stochastic event, which could be explained by increased
vascularisation and blood supply. Nonetheless, specific
molecular mechanisms underpinning the inflow of mes-
enchymal cells from bone marrow into synovium could
still be at play. Recent work has demonstrated that
placental growth factor, whose levels are increased in
rheumatoid arthritis joints, could recruit bone marrow
MSCs to the synovium [28].Conclusions
Taken together, our findings show a dual contribution
to the synovial hyperplasia following joint surface in-
jury from infiltration of bone marrow-derived cells,
which include haematopoietic cells and a minority of
Pdgfrα+ MSCs/fibroblasts, and proliferation of MSCs
that are likely tissue-resident. MSCs resident in
synovium and bone marrow-derived MSCs infiltrating
the synovium could be functionally distinct MSC
subpopulations. Lineage tracing studies will provide
further insights into the existence of distinct MSC
subpopulations, their specialised functions and their
possible plasticity in the context of joint health and
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